Literature DB >> 25638802

Tumor-associated macrophages in diffuse large B-cell lymphoma.

Robert Kridel1, Christian Steidl1, Randy D Gascoyne2.   

Abstract

Mesh：

Year:  2015        PMID： 25638802      PMCID： PMC4803134          DOI： 10.3324/haematol.2015.124008

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  23 in total

1.  Distribution of the CD68 macrophage/myeloid associated antigen.

Authors:  K A Pulford; A Sipos; J L Cordell; W P Stross; D Y Mason
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

Review 2.  Mechanisms of killing by anti-CD20 monoclonal antibodies.

Authors:  Martin J Glennie; Ruth R French; Mark S Cragg; Ronald P Taylor
Journal:  Mol Immunol       Date:  2007-09       Impact factor: 4.407

3.  Prognostic influence of macrophages in patients with diffuse large B-cell lymphoma: a correlative study from a Nordic phase II trial.

Authors:  Sari Riihijärvi; Idun Fiskvik; Minna Taskinen; Heli Vajavaara; Maria Tikkala; Olav Yri; Marja-Liisa Karjalainen-Lindsberg; Jan Delabie; Erlend Smeland; Harald Holte; Sirpa Leppä
Journal:  Haematologica       Date:  2014-11-07       Impact factor: 9.941

4.  High density of CD68+/CD163+ tumour-associated macrophages (M2-TAM) at diagnosis is significantly correlated to unfavorable prognostic factors and to poor clinical outcomes in patients with diffuse large B-cell lymphoma.

Authors:  Francesco Marchesi; Mariangela Cirillo; Antonella Bianchi; Michela Gately; Odoardo M Olimpieri; Elisabetta Cerchiara; Daniela Renzi; Alessandra Micera; Bjorn O Balzamino; Stefano Bonini; Andrea Onetti Muda; Giuseppe Avvisati
Journal:  Hematol Oncol       Date:  2014-04-08       Impact factor: 5.271

5.  An increase of M2 macrophages predicts poor prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone.

Authors:  Soo Jeong Nam; Heounjeong Go; Jin Ho Paik; Tae Min Kim; Dae Seog Heo; Chul Woo Kim; Yoon Kyung Jeon
Journal:  Leuk Lymphoma       Date:  2014-03-03

6.  Microvascular density, CD68 and tryptase expression in human diffuse large B-cell lymphoma.

Authors:  Christian Marinaccio; Giuseppe Ingravallo; Francesco Gaudio; Tommasina Perrone; Beatrice Nico; Eugenio Maoirano; Giorgina Specchia; Domenico Ribatti
Journal:  Leuk Res       Date:  2014-09-22       Impact factor: 3.156

7.  Revisiting the immune microenvironment of diffuse large B-cell lymphoma using a tissue microarray and immunohistochemistry: robust semi-automated analysis reveals CD3 and FoxP3 as potential predictors of response to R-CHOP.

Authors:  Rita Coutinho; Andrew J Clear; Emanuele Mazzola; Andrew Owen; Paul Greaves; Andrew Wilson; Janet Matthews; Abigail Lee; Rute Alvarez; Maria Gomes da Silva; José Cabeçadas; Donna Neuberg; Maria Calaminici; John G Gribben
Journal:  Haematologica       Date:  2014-11-25       Impact factor: 9.941

8.  Human leukocyte antigen-DR expression on flow cytometry and tumor-associated macrophages in diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone therapy: retrospective cohort study.

Authors:  Wataru Yamamoto; Naoya Nakamura; Naoto Tomita; Kengo Takeuchi; Yoshimi Ishii; Hiroyuki Takahashi; Reina Watanabe; Hirotaka Takasaki; Shigeki Motomura; Shoichi Kobayashi; Tomoyuki Yokose; Yoshiaki Ishigatsubo; Rika Sakai
Journal:  Leuk Lymphoma       Date:  2014-03-19

9.  Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study.

Authors:  H Holte; S Leppä; M Björkholm; O Fluge; S Jyrkkiö; J Delabie; C Sundström; M-L Karjalainen-Lindsberg; M Erlanson; A Kolstad; A Fosså; B Ostenstad; E Löfvenberg; M Nordström; R Janes; L M Pedersen; H Anderson; M Jerkeman; M Eriksson
Journal:  Ann Oncol       Date:  2012-12-17       Impact factor: 32.976

Review 10.  The tumour microenvironment in B cell lymphomas.

Authors:  David W Scott; Randy D Gascoyne
Journal:  Nat Rev Cancer       Date:  2014-07-10       Impact factor: 60.716
View more
  15 in total

1.  Plasmablastic Lymphomas: Characterization of Tumor Microenvironment Using CD163 and PD-1 Immunohistochemistry.

Authors:  Janice S Ahn; Ali Al-Habib; Jeffrey A Vos; Aliyah R Sohani; Oralia Barboza-Quintana; Juan P Flores; Sijin Wen; Flavia G Rosado
Journal:  Ann Clin Lab Sci       Date:  2020-03       Impact factor: 1.256

Review 2.  Role of the microenvironment across histological subtypes of NHL.

Authors:  Karin Tarte
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

3.  Gene expression profiling of gray zone lymphoma.

Authors:  Clémentine Sarkozy; Lauren Chong; Katsuyoshi Takata; Elizabeth A Chavez; Tomoko Miyata-Takata; Gerben Duns; Adèle Telenius; Merrill Boyle; Graham W Slack; Camille Laurent; Pedro Farinha; Thierry J Molina; Christiane Copie-Bergman; Diane Damotte; Gilles A Salles; Anja Mottok; Kerry J Savage; David W Scott; Alexandra Traverse-Glehen; Christian Steidl
Journal:  Blood Adv       Date:  2020-06-09

4.  Immune cells regulate VEGF signalling via release of VEGF and antagonistic soluble VEGF receptor-1.

Authors:  T Hoeres; M Wilhelm; M Smetak; E Holzmann; G Schulze-Tanzil; J Birkmann
Journal:  Clin Exp Immunol       Date:  2018-01-04       Impact factor: 4.330

5.  Mass cytometry defines distinct immune profile in germinal center B-cell lymphomas.

Authors:  Mikael Roussel; Faustine Lhomme; Caroline E Roe; Todd Bartkowiak; Pauline Gravelle; Camille Laurent; Thierry Fest; Jonathan M Irish
Journal:  Cancer Immunol Immunother       Date:  2020-01-09       Impact factor: 6.968

Review 6.  Targeting B cell receptor signalling in cancer: preclinical and clinical advances.

Authors:  Jan A Burger; Adrian Wiestner
Journal:  Nat Rev Cancer       Date:  2018-01-19       Impact factor: 60.716

Review 7.  Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications.

Authors:  Sotirios G Papageorgiou; Thomas P Thomopoulos; Ioannis Katagas; Anthi Bouchla; Vassiliki Pappa
Journal:  Ther Adv Hematol       Date:  2021-05-24

Review 8.  Mechanisms of PD-1/PD-L1 expression and prognostic relevance in non-Hodgkin lymphoma: a summary of immunohistochemical studies.

Authors:  Pauline Gravelle; Barbara Burroni; Sarah Péricart; Cédric Rossi; Christine Bezombes; Marie Tosolini; Diane Damotte; Pierre Brousset; Jean-Jacques Fournié; Camille Laurent
Journal:  Oncotarget       Date:  2017-07-04

9.  NSE from diffuse large B-cell lymphoma cells regulates macrophage polarization.

Authors:  Meng-Yuan Zhu; Wen-Jian Liu; Hua Wang; Wei-da Wang; Na-Wei Liu; Yue Lu
Journal:  Cancer Manag Res       Date:  2019-05-17       Impact factor: 3.989

10.  Automated macrophage counting in DLBCL tissue samples: a ROF filter based approach.

Authors:  Marcus Wagner; René Hänsel; Sarah Reinke; Julia Richter; Michael Altenbuchinger; Ulf-Dietrich Braumann; Rainer Spang; Markus Löffler; Wolfram Klapper
Journal:  Biol Proced Online       Date:  2019-07-01       Impact factor: 3.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.